Competition law in the pharmaceutical sector: Aspen fined for excessive pricing in Italy

drugs

The Italian Competition Authority (“ICA”) has recently found that Aspen Pharmacare had increased the prices for some of its oncohematological drugs up to 1500% and imposed to the South African multinational a 5 million Euro fine for violation of art. 102, letter a) of the TFEU. Aspen has already communicated that it will appeal the decision.

Continue reading “Competition law in the pharmaceutical sector: Aspen fined for excessive pricing in Italy”

Google held liable in Italy for abuse of economic dependence

abuse of economic dependenceAfter being investigated for an alleged breach of competition law, Google is now experiencing negative outcomes also in the context of private enforcement, as the Court of first instance of Milan held Big G liable for abuse of economic dependence. This concept is unknown to EU competition law and is a separate concept from the abuse of dominant position.

Continue reading “Google held liable in Italy for abuse of economic dependence”

Antitrust compliance programs and limitation of liability in Italy

Antitrust compliance programsSince fines issued by competition authorities are a major concern for companies, the implementation of antitrust compliance programs should be a priority for legal counsel. Indeed, antitrust fines are of a purely punitive nature and are usually followed by damage lawsuits filed by the harmed parties. Therefore, these fines amount to an abrupt loss and do not exempt the liable firm to compensate harmed parties for the damages suffered. As a consequence, all the companies involved in antitrust investigations should consider implementing a defensive strategy aimed at minimizing the amount of the fine. Continue reading “Antitrust compliance programs and limitation of liability in Italy”